Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milan Lukas

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Digestive Diseases (Basel, Switzerland)|November 20, 2010
Inflammatory bowel disease as a risk factor for colorectal cancerMilan Lukas
Inflammatory Bowel Diseases|September 26, 2008
What is the time for surgery in severe Crohn's disease?Milan Lukas
Postgraduate Medical Journal|October 28, 2006
What is the origin of ulcerative colitis? Still more questions than answersMilan Lukas, Martin Bortlik, Zdenek Maratka
Clinical Laboratory|December 21, 2006
Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice?Karin Malickova, Milan Lukas, Robert Donoval, et al.
Journal of Crohn'S & Colitis|March 24, 2025
Effect of tofacitinib exposure in utero and during breastfeeding on the immune status of exposed childKatarina Mitrova, Marta Kostrejova, Kristyna Zdychyncova, et al.
Clinical Therapeutics|March 19, 2016
Biosimilars: A Multidisciplinary PerspectiveMajed Khraishi, David Stead, Milan Lukas, et al.
Scandinavian Journal of Gastroenterology|July 15, 2020
Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics?Karin Malickova, Zuzana Kratka, Stepanka Luxova, et al.
European Journal of Gastroenterology & Hepatology|November 21, 2009
Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohortKarin Malickova, Peter L Lakatos, Martin Bortlik, et al.
Intestinal Research|February 5, 2020
Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseasesSang Hyoung Park, Jae Cheol Park, Milan Lukas, et al.
Inflammatory Bowel Diseases|November 9, 2010
Bile acid malabsorption in inflammatory bowel disease: assessment by serum markersMartin Lenicek, Dana Duricova, Viktor Komarek, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Digestive Diseases (Basel, Switzerland)|November 20, 2010
Inflammatory bowel disease as a risk factor for colorectal cancerMilan Lukas
Inflammatory Bowel Diseases|September 26, 2008
What is the time for surgery in severe Crohn's disease?Milan Lukas
Postgraduate Medical Journal|October 28, 2006
What is the origin of ulcerative colitis? Still more questions than answersMilan Lukas, Martin Bortlik, Zdenek Maratka
Clinical Laboratory|December 21, 2006
Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice?Karin Malickova, Milan Lukas, Robert Donoval, et al.
Journal of Crohn'S & Colitis|March 24, 2025
Effect of tofacitinib exposure in utero and during breastfeeding on the immune status of exposed childKatarina Mitrova, Marta Kostrejova, Kristyna Zdychyncova, et al.
Clinical Therapeutics|March 19, 2016
Biosimilars: A Multidisciplinary PerspectiveMajed Khraishi, David Stead, Milan Lukas, et al.
Scandinavian Journal of Gastroenterology|July 15, 2020
Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics?Karin Malickova, Zuzana Kratka, Stepanka Luxova, et al.
European Journal of Gastroenterology & Hepatology|November 21, 2009
Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohortKarin Malickova, Peter L Lakatos, Martin Bortlik, et al.
Intestinal Research|February 5, 2020
Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseasesSang Hyoung Park, Jae Cheol Park, Milan Lukas, et al.
Inflammatory Bowel Diseases|November 9, 2010
Bile acid malabsorption in inflammatory bowel disease: assessment by serum markersMartin Lenicek, Dana Duricova, Viktor Komarek, et al.
Pageof 8